COST-EFFECTIVENESS OF SUNITINIB AS SECOND-LINE TREATMENT FOR GASTROINTESTINAL STROMAL TUMOR(GIST) IN CHINA

被引：1
|
作者：
Ren, H. [1 ]
Zhang, J. [2 ]
Dong, P. [3 ]
机构：
[1] Pfizer China, Shanghai, Peoples R China
[2] Southern Med Univ, Guangzhou, Guangdong, Peoples R China
[3] Pfizer Investment Co Ltd, Beijing, Peoples R China
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.1162
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN145
引用
收藏
页码：A455 / A455
页数：1
相关论文
共 50 条
  • [41] Cost-Effectiveness of Everolimus for Second-Line Treatment of Metastatic Renal Cell Carcinoma in Serbia
    Mihajlovic, Jovan
    Pechlivanoglou, Petros
    Sabo, Ana
    Tomic, Zdenko
    Postma, Maarten J.
    CLINICAL THERAPEUTICS, 2013, 35 (12) : 1909 - 1922
  • [42] A budget-impact and cost-effectiveness model for second-line treatment of major depression
    Malone, Daniel C.
    JOURNAL OF MANAGED CARE PHARMACY, 2007, 13 (06): : S8 - S18
  • [43] Treatment of wild-type gastrointestinal stromal tumor (WT-GIST) with imatinib and sunitinib
    Murray, Matthew
    Hatcher, Helen
    Jessop, Flora
    Williams, Denise
    Carroll, Nicholas
    Bulusu, Ramesh
    Judson, Ian
    PEDIATRIC BLOOD & CANCER, 2008, 50 (02) : 386 - 388
  • [44] COST-EFFECTIVENESS OF SAXAGLIPTIN VERSUS ACARBOSE AS SECOND-LINE THERAPY IN TYPE 2 DIABETES IN CHINA
    Gu, S.
    Shao, H.
    Zeng, Y.
    Shi, L.
    Dong, H.
    VALUE IN HEALTH, 2016, 19 (07) : A898 - A898
  • [45] Cost-Effectiveness of Saxagliptin versus Acarbose as Second-Line Therapy in Type 2 Diabetes in China
    Gu, Shuyan
    Zeng, Yuhang
    Yu, Demin
    Hu, Xiaoqian
    Dong, Hengjin
    PLOS ONE, 2016, 11 (11):
  • [46] Cost-effectiveness of pembrolizumab versus docetaxel as second-line treatment of non-small cell lung cancer in China
    Shi, Yafei
    Chen, Wei
    Zhang, Yujun
    Bo, Mingming
    Li, Chunyu
    Zhang, Mingyu
    Li, Guohui
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (18)
  • [47] Cost-effectiveness of second-line therapies in adults with chronic immune thrombocytopenia
    Goshua, George
    Sinha, Pranay
    Kunst, Natalia
    Pischel, Lauren
    Lee, Alfred Ian
    Cuker, Adam
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (01) : 122 - 130
  • [48] COST-EFFECTIVENESS ANALYSIS OF SECOND-LINE PHARMACOLOGICAL TREATMENTS OF ACROMEGALY IN SPAIN
    Peral, C.
    Cordido, F.
    Gimeno, V
    Sanchez-Cenizo, L.
    Mir, N.
    Parrondo, J.
    VALUE IN HEALTH, 2017, 20 (09) : A557 - A558
  • [49] Pembrolizumab as second-line therapy of hepatocellular carcinoma: A cost-effectiveness analysis
    Chan, S.
    Chiang, C.
    Lee, S.
    Wong, I.
    Choi, H.
    ANNALS OF ONCOLOGY, 2020, 31 : S174 - S174
  • [50] Cost-effectiveness of precision medicine in gastrointestinal stromal tumor and gastric adenocarcinoma
    Zeichner, Simon B.
    Goldstein, Daniel A.
    Kohn, Christine
    Flowers, Christopher R.
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2017, 8 (03) : 513 - 523
12345